Plasma lipoprotein(a) is not a predictor for restenosis after elective high-pressure coronary stenting

Circulation

Volumn 98, Issue 12, 1998, Pages 1172-1177

  Ribichini, Flavio ^a   Steffenino, Giuseppe ^a   Dellavalle, Antonio ^a   Vado, Antonello ^a   Ferrero, Valeria ^a   Camilla, Terenzio ^a   Giubergia, Silvia ^a   Uslenghi, Eugenio ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Lipoprotein(a); Restenosis; Stents

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; COLORIMETRY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032558409     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.12.1172     Document Type: Article

References (41)

1. Genest J Jr, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PW, Salem DN, Schaefer EJ. Lipoprotein cholesterol, apolipoprotein A1 and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol. 1992;19: 792-802.
2. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented with angiography. Circulation. 1986;4:758-765.
3. Orth-Gomér K, Mittleman MA, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belik K, Kirkeeide R, Svane B, Rydén L. Lipoprotein (a) as a determinant of coronary heart disease in young women. Circulation. 1997;95:329-334.
4. Simons L, Friedlander Y, Simons J, McCallum J, Lipoprotein (a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo Study. Atherosclerosis. 1993;99:87-95.
5. Kinlay S, Dobson AJ, Heller RF, McElduff P, Alexander H, Dickenson J. Risk of primary and recurrent acute myocardial infarction from lipoprotein (a) in men and women. J Am Coll Cardiol. 1996;28:870-875.
6. Koschinsky ML, Marcovina SM. Lipoprotein (a): structural implications for pathophysiology. Int J Clin Lab Res. 1997;27:14-23.
7. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 1989;339:303-305.
8. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risk associated with lipoprotein (a). Nature. 1989;339: 301-303.
9. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science. 1993;260:1655-1658.
10. Bruckert E, Truffert J, Degennes JL, Lagarde JP, Bernard C, Federspiel MC, Giral P, Dairou F. Does electrophoresis reliably screen for high serum lipoprotein Lp(a)? Clin Chim Acta. 1990;188:71-78.
11. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a): a risk factor for myocardial infarction. Arteriosclerosis. 1988;8:398-401.
12. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. Apo(a) isoforms predict risk for coronary heart disease: a study of six populations. Arterioscler Thromb. 1992;12:1214-1226.
13. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolobon G, Quinci GB. Lipoprotein Lp(a), and the risk for myocardial infarction. Arteriosclerosis. 1981;38:51-61.
14. Reis GJ, Kuntz RE, Silverman DI, Pasternak RC. Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol. 1991;68: 1431-1435.
15. Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992; 85:1279-1285.
16. Hearn JA, Donohue BC, Ba'albaki H, Douglas JS, King SB III, Lembo NJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1992;69:736-739.
17. Benchimol D, Bonnet J, Benchimol H, Drouillet F, Duplaa C, Couffinhal T, Desgranges C, Bricaud H. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Int J Cardiol. 1993; 38:7-18.
18. Daida H, Lee YJ, Yokoi H, Kanoh T, Ishiwata S, Kato K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y, Yamada N, Noma A, Yamaguchi H, and the Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Am J Cardiol. 1994;73:1037-1040.
19. Cooke T, Sheahan R, Foley D, Reilly M, D'Arcy G, Jauch W, Gibney M, Gearty G, Crean P, Walsh M. Lipoprotein (a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 1994;89:1593-1598.
20. Yamamoto H, Imazu M, Yamabe T, Ueda H, Hattori Y, Yamakido M. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a). Am Heart J. 1995;130:1168-1173.
21. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein (a) is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995;91: 1403-1409.
22. Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB. Intravascular ultrasound to discern device-specific effects and mechanism of restenosis. Am J Cardiol. 1996;78(suppl A):18-22.
23. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?. J Am Coll Cardiol. 1995;25:516-520.
24. Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni, E, Camilla T, Vado A, Benetton G, Uslenghi E, Piazza A. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 1998;97:147-154.
25. Karadi I, Kostner GM, Gries A, Nimpf J, Romies L, Malle E. Lipoprotein (a), and plasminogen are immunochemically related. Biochim Biophys Acta. 1988;960:91-97.
26. Tiran A, Tiran B, Hojas S, Kostner GM, Wilders-Trushnig MM. Immunoquantification of lipoprotein (a): comparison of nephelometry with electroimmunodiffusion. J Clin Lab Anal. 1993;7:256-262.
27. Labeur C, Sheperd J, Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem. 1990;36: 591-597.
28. Robert B, Grandhomme M, Mainard F, Madec Y. Effect of storage of sera and lipoprotein (a) phenotypes on detection of lipoprotein (a) by a new agarose gel. Clin Chim Acta. 1994;225:195-201.
29. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
30. Horie H, Takahashi M, Izumi M, Takaoka A, Fujita T, Sakamoto T, Kilo O, Okamura H, Kinoshita M. Association of an acute reduction in lipoprotein (a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Circulation. 1997;96:166-173.
31. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanism of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94: 1247-1254.
32. Loscalzo J. The relation between atherosclerosis and thrombosis. Circulation. 1992;86(suppl III):III-95-III-99.
33. Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein (a): properties and immunochemical measurement. Clin Chem. 1990;36: 2019-2026.
34. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels: the Framingham Offspring Study. Circulation. 1993;87:1135-1141.
35. Weintraub WS, Kosinski AS, Brown CL, King SB. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 1993;21:6-14.
36. Rensing BJ, Hermans RM, Tijssen JG, Rutch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serruys PW. Luminal narrowing after percutaneous transluminal coronary angioplasty. Circulation. 1993;88:975-985.
37. Carrozza JP, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
38. Van Belle E, Bauters C, Hubert E, Bodart JC, Abomaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation. 1997;96:1454-1460.
39. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27: 528-535.
40. Uterman G. The mysteries of lipoprotein (a). Science. 1989;246:904-910.
41. Fortmann SP, Marcovina SM. Lipoprotein (a), a clinically elusive lipoprotein particle. Circulation. 1997;95:295-296.